시장보고서
상품코드
1855801

세계의 아토피 피부염 크림 시장 보고서(2025년)

Atopic Dermatitis Cream Global Market Report 2025

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

아토피 피부염 크림 시장 규모는 최근 몇 년 동안 강력하게 성장하고 있습니다. 2024년 49억 9,000만 달러로 평가되었고, 2025년에는 54억 2,000만 달러에 달하고, CAGR 8.8%로 성장할 전망입니다. 실적기간의 성장은 피부 건강에 대한 의식 증가, 아토피 피부염의 유병률 증가, 국소 요법에 대한 수요 증가, 피부과학 연구 확대, 소매점 및 온라인 채널을 통한 광범위한 가용성, 의료 상환 정책의 지원에 의해 초래되었습니다.

아토피 피부염 크림 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 CAGR 8.4%로 75억 달러로 성장할 전망입니다. 예측 기간 동안의 성장은 개인화된 피부과 솔루션에 대한 수요가 증가하고, 피부 상태를 모니터링하기 위한 디지털 건강 플랫폼의 채택 확대, 시판되는 비스테로이드성 크림의 광범위한 가용성, 소아 친화적인 제형에 대한 관심 증가에 의해 지원될 것으로 예측됩니다. 예측 기간 동안 예상되는 주요 동향으로는 스테로이드가 없는 제제의 채택, 생물학적 제제에 착상을 얻은 외용제의 진보, 나노기술 기반 전달 시스템의 사용, 맞춤 치료 접근법, 천연 성분 및 식물 성분의 흡수, 디지털 부착 도구의 통합, 텔레피부 플랫폼의 사용 증가 등이 있습니다.

습진 유병률 증가는 향후 아토피 피부염 크림 시장의 확대를 촉진할 것으로 예측됩니다. 습진은 가려움, 적색, 건조, 염증을 특징으로하는 피부 질환입니다. 습진 관리의 필요성은 알레르기와 민감한 피부의 증상을 경험하는 사람이 증가함에 따라 증가하고 있으며, 효과적인 치료 및 피부 관리 제품에 대한 수요가 증가하고 있습니다. 아토피 피부염 크림은 염증을 억제하고, 가려움증을 진정시키고, 피부 본래의 장벽을 회복시키고, 추가적인 자극과 감염을 방지함으로써 습진을 치료하고, 환부의 치유와 장기적인 피부 건강을 지원합니다. 예를 들어, 2024년 12월 호주에 본사를 둔 연구 기관인 왕립 호주 종합의학회는 호주인의 약 16%가 습진으로 고통받고 있으며 그 중 약 25%가 중증으로 분류된다고 보고했습니다. 이와 같이 습진 유병률의 상승은 아토피 피부염 크림 시장의 성장을 가속하고 있습니다.

아토피 피부염 크림 시장의 주요 기업는 혁신적인 스테로이드가 없는 치료의 개발, 보험 및 지원 프로그램을 통한 환자 접근의 확대, 보다 안전한 외용 옵션을 통한 증상의 장기적인 관리 확보에 주력하고 있습니다. 스테로이드를 사용하지 않는 치료법은 스테로이드와 관련된 위험 없이 염증과 피부 문제를 안전하게 치료함으로써 코르티코스테로이드를 대체할 수 있는 옵션을 제공합니다. 예를 들어, 2024년 7월 미국 바이오 의약품 회사인 아크티스 바이오세라퓨틱스사는 6세 이상의 성인 및 소아의 경도에서 중등도의 아토피 피부염 치료제로 졸리브(로플루미라스트) 크림 0.15%를 미국에서 출시했습니다. 1일 1회 적용된 스테로이드가 없는 크림은 기존의 국소 치료에 흔히 나타나는 부작용을 동반하지 않고 가려움증을 신속하게 완화하고 질병 클리어런스를 높이고 장기 통제를 지원하도록 처방됩니다. ZORYVE는 일부 Pharmacy Benefit Manager 계약에 따라 보험 적용 약국에서 구입할 수 있습니다.

자주 묻는 질문

  • 아토피 피부염 크림 시장 규모는 어떻게 변화하고 있나요?
  • 아토피 피부염 크림 시장의 성장 요인은 무엇인가요?
  • 아토피 피부염 크림 시장에서 주요 기업들은 어떤 전략을 취하고 있나요?
  • 아토피 피부염 크림의 주요 성분 및 제형은 무엇인가요?
  • 아토피 피부염 크림 시장의 주요 동향은 무엇인가요?

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

  • 세계의 아토피 피부염 크림 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
  • 최종 이용 산업의 분석
  • 세계의 아토피 피부염 크림 시장 : 성장률 분석
  • 세계의 아토피 피부염 크림 시장 실적: 규모와 성장, 2019년-2024년
  • 세계의 아토피 피부염 크림 시장 예측 : 규모와 성장, 2024년-2029년, 2034년
  • 세계의 아토피 피부염 크림 : 총 잠재 시장 규모(TAM)

제6장 시장 세분화

  • 세계의 아토피 피부염 크림 시장 : 제품 유형별, 분석과 예측, 2019년-2024년, 2024년-2029년, 2034년
  • 코르티코스테로이드 크림
  • 칼시뉴린 억제제 크림
  • PDE4 억제제 크림
  • 보습 크림
  • 기타 제품 유형
  • 세계의 아토피 피부염 크림 시장 : 연령층별, 분석과 예측, 2019년-2024년, 2024년-2029년, 2034년
  • 소아
  • 성인
  • 고령자
  • 세계의 아토피 피부염 크림 시장 : 유통 채널별, 분석과 예측, 2019년-2024년, 2024년-2029년, 2034년
  • 병원 약국
  • 소매 약국
  • 온라인 약국
  • 기타 유통 채널
  • 세계의 아토피 피부염 크림 시장 : 세분화 코르티코스테로이드 크림, 유형별, 분석과 예측, 2019년-2024년, 2024년-2029년, 2034년
  • 저강도 코르티코스테로이드
  • 중강도 코르티코스테로이드
  • 고강도 코르티코스테로이드
  • 초고강도 코르티코스테로이드
  • 세계의 아토피 피부염 크림 시장 : 세분화 칼시뉴린 억제제 크림: 유형별, 분석과 예측, 2019년-2024년, 2024년-2029년, 2034년
  • 타크로리무스 연고
  • 피메크롤리무스 크림
  • 기타 칼시뉴린 억제제
  • 세계의 아토피 피부염 크림 시장 : 세분화 PDE4 억제제 크림: 유형별, 분석과 예측, 2019년-2024년, 2024년-2029년, 2034년
  • 크리사보롤 연고
  • 로플루밀라스트 크림
  • 기타 PDE4 억제제
  • 세계의 아토피 피부염 크림 시장 : 세분화 보습 크림, 유형별, 분석과 예측, 2019년-2024년, 2024년-2029년, 2034년
  • 에몰리언트 베이스의 보습제
  • 보습제 베이스의 보습제
  • 피부 장벽 차단형 보습제
  • 세라마이드 함유 보습제
  • 세계의 아토피 피부염 크림 시장 : 세분화 기타 제품 유형, 유형별, 분석과 예측, 2019년-2024년, 2024년-2029년, 2034년
  • JAK 억제제 크림
  • 항히스타민 크림
  • 허브 또는 천연 크림
  • 콤비네이션 크림

제7장 지역별/국가별 분석

  • 세계의 아토피 피부염 크림 시장 : 지역별, 분석과 예측, 2019년-2024년, 2024년-2029년, 2034년
  • 세계의 아토피 피부염 크림 시장 : 국가별, 분석과 예측, 2019년-2024년, 2024년-2029년, 2034년

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

  • 아토피 피부염 크림 시장 : 경쟁 구도
  • 아토피 피부염 크림 시장 : 기업 프로파일
    • Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
    • AbbVie Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
    • Bayer AG : 개요, 제품 및 서비스, 전략 및 재무 분석
    • Sanofi SA : 개요, 제품 및 서비스, 전략 및 재무 분석
    • AstraZeneca plc : 개요, 제품 및 서비스, 전략 및 재무 분석

제31장 기타 주요 기업 및 혁신 기업

  • GlaxoSmithKline plc
  • Eli Lilly and Company
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc
  • Regeneron Pharmaceuticals, Inc.
  • Astellas Pharma Inc.
  • Bausch Health Companies Inc.
  • Organon & Co.
  • Galderma SA
  • Incyte Corporation
  • Leo Pharma A/S
  • Almirall SA
  • Boehringer Ingelheim
  • Arcutis Biotherapeutics Inc.
  • Medimetriks Pharmaceuticals, Inc.

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

  • 아토피 피부염 크림 시장 2029년 : 새로운 기회를 제공하는 국가
  • 아토피 피부염 크림 시장 2029년 : 새로운 기회를 제공하는 부문
  • 아토피 피부염 크림 시장 2029년 : 성장 전략
    • 시장 동향에 기초한 전략
    • 경쟁 전략

제36장 부록

SHW 25.12.15

An atopic dermatitis cream is a topical formulation, often corticosteroid-, emollient-, or non-steroidal-based, designed to soothe inflammation, relieve itching, and restore the skin barrier in patients with chronic eczema. These creams help maintain hydration, reduce flare-ups, and improve comfort in daily skin care.

The primary product categories of atopic dermatitis creams include corticosteroid creams, calcineurin inhibitor creams, PDE4 inhibitor creams, moisturizing creams, and others. Corticosteroid creams are topical medications applied directly to the skin to reduce inflammation, redness, and itching by modulating immune responses in conditions such as eczema. These products are used across pediatric, adult, and geriatric age groups and are distributed through hospital pharmacies, retail pharmacies, online pharmacies, and other channels.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The atopic dermatitis cream market research report is one of a series of new reports from The Business Research Company that provides atopic dermatitis cream market statistics, including the atopic dermatitis cream industry global market size, regional shares, competitors with the atopic dermatitis cream market share, detailed atopic dermatitis cream market segments, market trends, and opportunities, and any further data you may need to thrive in the atopic dermatitis cream industry. This atopic dermatitis cream market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The atopic dermatitis cream market size has grown strongly in recent years. It will grow from $4.99 billion in 2024 to $5.42 billion in 2025 at a compound annual growth rate (CAGR) of 8.8%. The growth during the historic period was driven by increasing awareness of skin health, rising prevalence of atopic dermatitis, growing demand for topical therapies, expansion of dermatology research, wider availability through retail and online channels, and supportive healthcare reimbursement policies.

The atopic dermatitis cream market size is expected to see strong growth in the next few years. It will grow to $7.50 billion in 2029 at a compound annual growth rate (CAGR) of 8.4%. The growth during the forecast period is expected to be supported by higher demand for personalized dermatology solutions, growing adoption of digital health platforms for monitoring skin conditions, wider availability of over-the-counter non-steroidal creams, and greater focus on pediatric-friendly formulations. Key trends anticipated in the forecast period include the adoption of steroid-free formulations, advancements in biologic-inspired topicals, use of nanotechnology-based delivery systems, personalized treatment approaches, incorporation of natural and botanical ingredients, integration of digital adherence tools, and increased use of teledermatology platforms.

The increasing prevalence of eczema is expected to drive the expansion of the atopic dermatitis cream market in the future. Eczema is a skin disorder characterized by itching, redness, dryness, and inflammation. The need for eczema care is growing as more individuals experience allergies and sensitive skin conditions, increasing demand for effective treatments and skincare products. Atopic dermatitis cream helps treat eczema by reducing inflammation, calming itching, restoring the skin's natural barrier, and preventing further irritation or infection, thereby supporting healing and long-term skin health in affected areas. For example, in December 2024, the Royal Australian College of General Practitioners, a research institute based in Australia, reported that approximately sixteen percent of Australians suffer from eczema, with about twenty-five percent of these cases classified as severe. Thus, the rising prevalence of eczema is driving growth in the atopic dermatitis cream market.

Key players in the atopic dermatitis cream market are focusing on developing innovative steroid-free treatments, increasing patient access through insurance and support programs, and ensuring long-term management of the condition with safer topical options. Steroid-free therapies offer alternatives to corticosteroids by treating inflammation and skin issues safely without the risks associated with steroids. For instance, in July 2024, Arcutis Biotherapeutics Inc., a biopharmaceutical company based in the United States, introduced ZORYVE (roflumilast) cream 0.15 percent in the U.S. for the treatment of mild to moderate atopic dermatitis in adults and children aged six years and older. This once-daily steroid-free cream is formulated to provide rapid relief from itching, enhance disease clearance, and support long-term control without the common side effects linked to traditional topical treatments. ZORYVE is available at pharmacies with immediate insurance coverage under select pharmacy benefit manager contracts.

In October 2024, Organon & Co., a pharmaceutical company based in the United States, acquired Dermavant Sciences Ltd. for an undisclosed sum. This acquisition strengthens Organon's dermatology portfolio by adding VTAMA, a first-in-class nonbiologic, non-steroidal topical therapy for plaque psoriasis, which also has potential approval for atopic dermatitis. Dermavant Sciences Ltd. is a pharmaceutical company based in the United States specializing in therapeutic solutions for dermatological conditions.

Major players in the atopic dermatitis cream market are Pfizer Inc., AbbVie Inc., Bayer AG, Sanofi S.A., AstraZeneca plc, GlaxoSmithKline plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Viatris Inc, Regeneron Pharmaceuticals, Inc., Astellas Pharma Inc., Bausch Health Companies Inc., Organon & Co., Galderma S.A., Incyte Corporation, Leo Pharma A/S, Almirall S.A., Boehringer Ingelheim, Arcutis Biotherapeutics Inc., Medimetriks Pharmaceuticals Inc.

North America was the largest region in the atopic dermatitis cream market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in atopic dermatitis cream report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the atopic dermatitis cream market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The atopic dermatitis cream market consists of sales of barrier repair creams, antihistamine-infused creams, ceramide-enriched creams, herbal and plant-based creams, and probiotic-infused creams. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Atopic Dermatitis Cream Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on atopic dermatitis cream market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for atopic dermatitis cream ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The atopic dermatitis cream market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Corticosteroid Creams; Calcineurin Inhibitor Creams; PDE4 Inhibitor Creams; Moisturizing Creams; Other Product Types
  • 2) By Age Group: Pediatric; Adult; Geriatric
  • 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
  • Subsegments:
  • 1) By Corticosteroid Creams: Low-Potency Corticosteroids; Medium-Potency Corticosteroids; High-Potency Corticosteroids; Ultra-High Potency Corticosteroids
  • 2) By Calcineurin Inhibitor Creams: Tacrolimus Ointment; Pimecrolimus Cream; Other Calcineurin Inhibitors
  • 3) By PDE4 Inhibitor Creams: Crisaborole Ointment; Roflumilast Cream; Other PDE4 Inhibitors
  • 4) By Moisturizing Creams: Emollient-Based Moisturizers; Humectant-Based Moisturizers; Occlusive Moisturizers; Ceramide-Containing Moisturizers
  • 5) By Other Product Types: JAK Inhibitor Creams; Antihistamine Creams; Herbal Or Natural Topical Creams; Combination Creams
  • Companies Mentioned: Pfizer Inc.; AbbVie Inc.; Bayer AG; Sanofi S.A.; AstraZeneca plc; GlaxoSmithKline plc; Eli Lilly and Company; Teva Pharmaceutical Industries Ltd.; Viatris Inc; Regeneron Pharmaceuticals, Inc.; Astellas Pharma Inc.; Bausch Health Companies Inc.; Organon & Co.; Galderma S.A.; Incyte Corporation; Leo Pharma A/S; Almirall S.A.; Boehringer Ingelheim; Arcutis Biotherapeutics Inc.; Medimetriks Pharmaceuticals, Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Atopic Dermatitis Cream Market Characteristics

3. Atopic Dermatitis Cream Market Trends And Strategies

4. Atopic Dermatitis Cream Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Atopic Dermatitis Cream Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Atopic Dermatitis Cream PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Atopic Dermatitis Cream Market Growth Rate Analysis
  • 5.4. Global Atopic Dermatitis Cream Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Atopic Dermatitis Cream Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Atopic Dermatitis Cream Total Addressable Market (TAM)

6. Atopic Dermatitis Cream Market Segmentation

  • 6.1. Global Atopic Dermatitis Cream Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Corticosteroid Creams
  • Calcineurin Inhibitor Creams
  • PDE4 Inhibitor Creams
  • Moisturizing Creams
  • Other Product Types
  • 6.2. Global Atopic Dermatitis Cream Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pediatric
  • Adult
  • Geriatric
  • 6.3. Global Atopic Dermatitis Cream Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Other Distribution Channels
  • 6.4. Global Atopic Dermatitis Cream Market, Sub-Segmentation Of Corticosteroid Creams, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Low-Potency Corticosteroids
  • Medium-Potency Corticosteroids
  • High-Potency Corticosteroids
  • Ultra-High Potency Corticosteroids
  • 6.5. Global Atopic Dermatitis Cream Market, Sub-Segmentation Of Calcineurin Inhibitor Creams, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Tacrolimus Ointment
  • Pimecrolimus Cream
  • Other Calcineurin Inhibitors
  • 6.6. Global Atopic Dermatitis Cream Market, Sub-Segmentation Of PDE4 Inhibitor Creams, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Crisaborole Ointment
  • Roflumilast Cream
  • Other PDE4 Inhibitors
  • 6.7. Global Atopic Dermatitis Cream Market, Sub-Segmentation Of Moisturizing Creams, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Emollient-Based Moisturizers
  • Humectant-Based Moisturizers
  • Occlusive Moisturizers
  • Ceramide-Containing Moisturizers
  • 6.8. Global Atopic Dermatitis Cream Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • JAK Inhibitor Creams
  • Antihistamine Creams
  • Herbal Or Natural Topical Creams
  • Combination Creams

7. Atopic Dermatitis Cream Market Regional And Country Analysis

  • 7.1. Global Atopic Dermatitis Cream Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Atopic Dermatitis Cream Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Atopic Dermatitis Cream Market

  • 8.1. Asia-Pacific Atopic Dermatitis Cream Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Atopic Dermatitis Cream Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Atopic Dermatitis Cream Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Atopic Dermatitis Cream Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Atopic Dermatitis Cream Market

  • 9.1. China Atopic Dermatitis Cream Market Overview
  • 9.2. China Atopic Dermatitis Cream Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Atopic Dermatitis Cream Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Atopic Dermatitis Cream Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Atopic Dermatitis Cream Market

  • 10.1. India Atopic Dermatitis Cream Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Atopic Dermatitis Cream Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Atopic Dermatitis Cream Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Atopic Dermatitis Cream Market

  • 11.1. Japan Atopic Dermatitis Cream Market Overview
  • 11.2. Japan Atopic Dermatitis Cream Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Atopic Dermatitis Cream Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Atopic Dermatitis Cream Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Atopic Dermatitis Cream Market

  • 12.1. Australia Atopic Dermatitis Cream Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Atopic Dermatitis Cream Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Atopic Dermatitis Cream Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Atopic Dermatitis Cream Market

  • 13.1. Indonesia Atopic Dermatitis Cream Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Atopic Dermatitis Cream Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Atopic Dermatitis Cream Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Atopic Dermatitis Cream Market

  • 14.1. South Korea Atopic Dermatitis Cream Market Overview
  • 14.2. South Korea Atopic Dermatitis Cream Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Atopic Dermatitis Cream Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Atopic Dermatitis Cream Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Atopic Dermatitis Cream Market

  • 15.1. Western Europe Atopic Dermatitis Cream Market Overview
  • 15.2. Western Europe Atopic Dermatitis Cream Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Atopic Dermatitis Cream Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Atopic Dermatitis Cream Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Atopic Dermatitis Cream Market

  • 16.1. UK Atopic Dermatitis Cream Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Atopic Dermatitis Cream Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Atopic Dermatitis Cream Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Atopic Dermatitis Cream Market

  • 17.1. Germany Atopic Dermatitis Cream Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Atopic Dermatitis Cream Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Atopic Dermatitis Cream Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Atopic Dermatitis Cream Market

  • 18.1. France Atopic Dermatitis Cream Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Atopic Dermatitis Cream Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Atopic Dermatitis Cream Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Atopic Dermatitis Cream Market

  • 19.1. Italy Atopic Dermatitis Cream Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Atopic Dermatitis Cream Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Atopic Dermatitis Cream Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Atopic Dermatitis Cream Market

  • 20.1. Spain Atopic Dermatitis Cream Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Atopic Dermatitis Cream Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Atopic Dermatitis Cream Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Atopic Dermatitis Cream Market

  • 21.1. Eastern Europe Atopic Dermatitis Cream Market Overview
  • 21.2. Eastern Europe Atopic Dermatitis Cream Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Atopic Dermatitis Cream Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Atopic Dermatitis Cream Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Atopic Dermatitis Cream Market

  • 22.1. Russia Atopic Dermatitis Cream Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Atopic Dermatitis Cream Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Atopic Dermatitis Cream Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Atopic Dermatitis Cream Market

  • 23.1. North America Atopic Dermatitis Cream Market Overview
  • 23.2. North America Atopic Dermatitis Cream Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Atopic Dermatitis Cream Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Atopic Dermatitis Cream Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Atopic Dermatitis Cream Market

  • 24.1. USA Atopic Dermatitis Cream Market Overview
  • 24.2. USA Atopic Dermatitis Cream Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Atopic Dermatitis Cream Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Atopic Dermatitis Cream Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Atopic Dermatitis Cream Market

  • 25.1. Canada Atopic Dermatitis Cream Market Overview
  • 25.2. Canada Atopic Dermatitis Cream Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Atopic Dermatitis Cream Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Atopic Dermatitis Cream Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Atopic Dermatitis Cream Market

  • 26.1. South America Atopic Dermatitis Cream Market Overview
  • 26.2. South America Atopic Dermatitis Cream Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Atopic Dermatitis Cream Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Atopic Dermatitis Cream Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Atopic Dermatitis Cream Market

  • 27.1. Brazil Atopic Dermatitis Cream Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Atopic Dermatitis Cream Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Atopic Dermatitis Cream Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Atopic Dermatitis Cream Market

  • 28.1. Middle East Atopic Dermatitis Cream Market Overview
  • 28.2. Middle East Atopic Dermatitis Cream Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Atopic Dermatitis Cream Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Atopic Dermatitis Cream Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Atopic Dermatitis Cream Market

  • 29.1. Africa Atopic Dermatitis Cream Market Overview
  • 29.2. Africa Atopic Dermatitis Cream Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Atopic Dermatitis Cream Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Atopic Dermatitis Cream Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Atopic Dermatitis Cream Market Competitive Landscape And Company Profiles

  • 30.1. Atopic Dermatitis Cream Market Competitive Landscape
  • 30.2. Atopic Dermatitis Cream Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

31. Atopic Dermatitis Cream Market Other Major And Innovative Companies

  • 31.1. GlaxoSmithKline plc
  • 31.2. Eli Lilly and Company
  • 31.3. Teva Pharmaceutical Industries Ltd.
  • 31.4. Viatris Inc
  • 31.5. Regeneron Pharmaceuticals, Inc.
  • 31.6. Astellas Pharma Inc.
  • 31.7. Bausch Health Companies Inc.
  • 31.8. Organon & Co.
  • 31.9. Galderma S.A.
  • 31.10. Incyte Corporation
  • 31.11. Leo Pharma A/S
  • 31.12. Almirall S.A.
  • 31.13. Boehringer Ingelheim
  • 31.14. Arcutis Biotherapeutics Inc.
  • 31.15. Medimetriks Pharmaceuticals, Inc.

32. Global Atopic Dermatitis Cream Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Atopic Dermatitis Cream Market

34. Recent Developments In The Atopic Dermatitis Cream Market

35. Atopic Dermatitis Cream Market High Potential Countries, Segments and Strategies

  • 35.1 Atopic Dermatitis Cream Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Atopic Dermatitis Cream Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Atopic Dermatitis Cream Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제